IE 11 is not supported. For an optimal experience visit our site on another browser.

Eli Lilly pauses vaccine trial as spike in coronavirus cases raises alarms


Drug maker Eli Lilly says it’s pausing enrollment on its experimental COVID antibody treatments, now at the critical Phase 3 stage of the process. It’s just the latest obstacle in the race to develop vaccines and treatments for the coronavirus. NBC national correspondent Miguel Almaguer reports for TODAY.